| Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis SS Hasan, T Capstick, R Ahmed, CS Kow, F Mazhar, HA Merchant, ... Expert review of respiratory medicine 14 (11), 1149-1163, 2020 | 266 | 2020 |
| Meta-analysis of effect of statins in patients with COVID-19 CS Kow, SS Hasan American Journal of Cardiology 134, 153-155, 2020 | 193 | 2020 |
| Worldwide survey of COVID-19–associated arrhythmias EJ Coromilas, S Kochav, I Goldenthal, A Biviano, H Garan, S Goldbarg, ... Circulation: Arrhythmia and Electrophysiology 14 (3), e009458, 2021 | 177 | 2021 |
| Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis SS Hasan, S Radford, CS Kow, STR Zaidi Journal of thrombosis and thrombolysis 50, 814-821, 2020 | 125 | 2020 |
| Surging trends in prescriptions and costs of antidepressants in England amid COVID-19 SA Rabeea, HA Merchant, MU Khan, CS Kow, SS Hasan DARU Journal of Pharmaceutical Sciences 29, 217-221, 2021 | 91 | 2021 |
| Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: a meta-analysis CS Kow, SS Hasan Journal of medical virology 93 (2), 695-697, 2021 | 79 | 2021 |
| Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies CS Kow, SS Hasan Inflammopharmacology 29, 1075-1090, 2021 | 74 | 2021 |
| Social distancing and the use of PPE by community pharmacy personnel: Does evidence support these measures? SS Hasan, CS Kow, STR Zaidi Research in Social and Administrative Pharmacy 17 (2), 456-459, 2021 | 58 | 2021 |
| Use of corticosteroids in asthma and COPD patients with or without COVID-19 SS Hasan, T Capstick, STR Zaidi, CS Kow, HA Merchant Respiratory medicine 170, 106045, 2020 | 54 | 2020 |
| Antimicrobial consumption among hospitalized patients with COVID-19 in Pakistan Z Ul Mustafa, M Salman, M Aldeyab, CS Kow, SS Hasan SN comprehensive clinical medicine 3 (8), 1691-1695, 2021 | 47 | 2021 |
| The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis CS Kow, HA Merchant, ZU Mustafa, SS Hasan Pharmacological Reports, 1-7, 2021 | 47 | 2021 |
| Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID‐19: a meta‐analysis. CS Kow, SS Hasan Journal of Internal Medicine 289 (1), 2021 | 47 | 2021 |
| An evaluation of medication appropriateness and frailty among residents of aged care homes in Malaysia: A cross-sectional study SS Hasan, CS Kow, RK Verma, SI Ahmed, P Mittal, DWK Chong Medicine 96 (35), e7929, 2017 | 44 | 2017 |
| Mortality and disease severity among COVID-19 patients receiving renin-angiotensin system inhibitors: a systematic review and meta-analysis SS Hasan, CS Kow, MA Hadi, STR Zaidi, HA Merchant American Journal of Cardiovascular Drugs 20, 571-590, 2020 | 43 | 2020 |
| Cardiovascular disease and use of renin-angiotensin system inhibitors in COVID-19 CS Kow, STR Zaidi, SS Hasan American Journal of Cardiovascular Drugs 20, 217-221, 2020 | 41 | 2020 |
| Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis CS Kow, SS Hasan Journal of thrombosis and thrombolysis 52, 124-129, 2021 | 36 | 2021 |
| Management of outpatient warfarin therapy amid COVID-19 pandemic: a practical guide CS Kow, W Sunter, A Bain, STR Zaidi, SS Hasan American Journal of Cardiovascular Drugs 20, 301-309, 2020 | 35 | 2020 |
| Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease CS Kow, SS Hasan Rheumatology International 40 (12), 2117-2118, 2020 | 34 | 2020 |
| The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials CS Kow, SS Hasan European journal of clinical pharmacology 77, 1089-1094, 2021 | 32 | 2021 |
| Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients SS Hasan, CS Kow, A Bain, S Kavanagh, HA Merchant, MA Hadi Expert opinion on pharmacotherapy 22 (2), 229-240, 2021 | 30 | 2021 |
